Share

Investor Information

Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference

Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference

Register Here
Johnson & Johnson to Participate in the Cowen 43^rd Annual HealthCare Conference

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
NYSE: JNJ $163.61 $0.00 (0.000%)
- Day High $164.56
- Day Low $162.90
- Volume 2,134
Last Updated: 2/08/2023 04.10 PM

2022 Annual Meeting of Shareholders

2022 Annual Meeting of Shareholders

Annual Meeting Materials and Webcast

2022 ESG Investor Update Webcast

2022 ESG Investor Update Webcast

Learn More

Latest News Releases

Latest News

February 02, 2023

Johnson & Johnson to Participate in the Cowen 43^rd Annual HealthCare Conference
Latest News

January 18, 2023

Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
Financial

January 03, 2023

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023

See All News Releases

Webcast: Pharmaceutical Business Review 2021

Webcast: Pharmaceutical Business Review 2021

2021 Health for Humanity Report

2021 Health for Humanity Report

2021 Janssen U.S. Transparency Report

2021 Janssen U.S. Transparency Report

2021 Annual Report

2021 Annual Report

Investor Relations

Quarterly Results

See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.

Learn More
Shareholder Tools
- Email Alerts Subscription
- RSS News Feeds

Investor FAQs

Answers to common questions regarding purchasing and owning Johnson & Johnson stock.

Learn More

ESG Resources

Effective management of ESG matters is a business imperative.

Learn More

Contact Investor Relations

Questions? Please contact Investor Relations: